NASDAQ: LIMN
Liminatus Pharma Inc Stock Ownership - Who owns Liminatus Pharma?

Insider buying vs selling

Have Liminatus Pharma Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when LIMN insiders and whales buy or sell their stock.

LIMN Shareholders

What type of owners hold Liminatus Pharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Iris Acquisition Holdings LLC513.70%6,900,000$19.25MInsider
Chris Kim459.30%6,169,406$17.21MInsider
Ewon Comfortech Co Ltd409.47%5,500,000$15.35MInsider
Valetudo Therapeutics LLC390.44%5,244,351$14.63MInsider
Kh Feelux Co Ltd297.79%4,000,000$11.16MInsider
Cygnus Capital Advisors LLC0.02%329$917.91Institution
Xtxtop0.02%222$619.38Institution
Xtx Topco Ltd0.02%221$616.59Institution
Geodec0.01%138$385.02Institution
Geode Capital Management LLC0.01%138$385.02Institution

1 of 3

LIMN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
LIMN0.00%100.00%
CVKD0.00%28.17%Net Selling
CANF0.00%0.00%
DRMA0.00%100.00%Net Buying
PMCB0.01%16.46%Net Selling

Liminatus Pharma Stock Ownership FAQ

Who owns Liminatus Pharma?

Liminatus Pharma (NASDAQ: LIMN) is owned by 0.07% institutional shareholders, 2,070.70% Liminatus Pharma insiders, and 0.00% retail investors. Iris Acquisition Holdings LLC is the largest individual Liminatus Pharma shareholder, owning 6.90M shares representing 513.70% of the company. Iris Acquisition Holdings LLC's Liminatus Pharma shares are currently valued at $19.28M.

If you're new to stock investing, here's how to buy Liminatus Pharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.